<i>Azadirachta indica</i> Seed Derived Carbon Nanocapsules: Cell Imaging, Depolarization of Mitochondrial Membrane Potential, and Dose-Dependent Control Death of Breast Cancer-Reference-Cited by-同舟云学术

Azadirachta indica Seed Derived Carbon Nanocapsules: Cell Imaging, Depolarization of Mitochondrial Membrane Potential, and Dose-Dependent Control Death of Breast Cancer

Published:2022-07-27 Issue:8 Volume:8 Page:3608-3622
ISSN:2373-9878
Container-title:ACS Biomaterials Science & Engineering
language:en
Short-container-title:ACS Biomater. Sci. Eng.

Author:

Maity Somedutta¹,Tomar Munendra Singh²³^ORCID,Wasnik Kirti²,Patra Sukanya²,Modak Monami Das¹,Gupta Prem Shankar²,Pareek Divya²,Singh Monika²,Paik Pradip²^ORCID

Affiliation:

1. School of Engineering Sciences and Technology, University of Hyderabad, Hyderabad 500046, Telangana, India

2. School of Biomedical Engineering, Indian Institute of Technology (BHU), Varanasi 221 005, Uttar Pradesh, India

3. Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado 80045, United States

Funder

Science and Engineering Research Board

Department of Science and Technology, Ministry of Science and Technology

Council for Scientific and Industrial Research

Publisher

American Chemical Society (ACS)

Subject

Biomedical Engineering,Biomaterials

Link

https://pubs.acs.org/doi/pdf/10.1021/acsbiomaterials.2c00463

Reference73 articles.

1. Nanomaterials for Theranostics: Recent Advances and Future Challenges

2. Nanomaterials for Nanotheranostics: Tuning Their Properties According to Disease Needs

3. Engineering precision nanoparticles for drug delivery

4. High-Performance Near-Infrared Aggregation-Induced Emission Luminogen with Mitophagy Regulating Capability for Multimodal Cancer Theranostics

5. Theranostic Nanoshells: From Probe Design to Imaging and Treatment of Cancer

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polymeric nanomaterials-based theranostic platforms for triple-negative breast cancer (TNBC) treatment;International Journal of Pharmaceutics;2024-07